|
May 14
|
3 Magnificent Stocks That Are Passive Income Machines
|
|
May 13
|
Wegovy weight loss sustained for four years in trial, Novo Nordisk says
|
|
May 13
|
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
|
|
May 11
|
1 No-Brainer Growth Stock to Buy and Hold
|
|
May 11
|
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
|
|
May 10
|
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
|
|
May 10
|
How A Top Fund Beats The Market By Owning Future Leaders
|
|
May 10
|
Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
|
|
May 10
|
Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
|
|
May 10
|
UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
|
|
May 9
|
Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
|
|
May 9
|
3 Stocks to Buy Following Guidance Upgrades
|
|
May 9
|
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
|
|
May 8
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Feb 12
|
Could Eli Lilly's Zepbound Become the World's Best-Selling Drug?
|
|
Feb 10
|
CVS chief medical officer: 'We are not looking to build the entire healthcare delivery ecosystem'
|
|
Feb 10
|
Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock?
|
|
Feb 10
|
30 Most Valuable Drug Companies in 2024
|
|
Feb 10
|
3 Stocks That Could Trounce the Market in 2024
|